Covid: Evusheld antibody protection ruled out for most vulnerable

Covid: Evusheld antibody protection ruled out for most vulnerable A Covid protection for people with weakened immune systems has been shelved in the UK because of a lack of evidence over how well it works against the Omicron variant.

The Department of Health said it would not be buying doses of the Evusheld injection. BBC News

See also:

• Levels of the 'stress hormone' are key indicators as to whether a person will suffer long-Covid The Daily Mail
• UK decision not to buy Covid drug Evusheld disappoints charities The Guardian
• Government urged to classify Covid as an occupational disease The Guardian